RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000068.xml
PDF herunterladen
Semin intervent Radiol 2011; 28(3): 273-282
DOI: 10.1055/s-0031-1284453
© Thieme Medical PublishersDOI: 10.1055/s-0031-1284453
Medical and Endoscopic Management of Gastric Varices
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
15. August 2011 (online)
ABSTRACT
In the past 20 years, our understanding of the pathophysiology and management options among patients with gastric varices (GV) has changed significantly. GV are the most common cause of upper gastrointestinal bleeding in patients with portal hypertension after esophageal varices (EV) and generally have more severe bleeding than EV. In the United States, the majority of GV patients have underlying portal hypertension rather than splenic vein thrombosis. The widely used classifications are the Sarin Endoscopic Classification and the Japanese Vascular Classifications. The former is based on the endoscopic appearance and location of the varices, while the Japanese classification is based on the underlying vascular anatomy. In this article, the authors address the current concepts of classification, epidemiology, pathophysiology, and emerging management options of gastric varices. They describe the stepwise approach to patients with gastric varices, including the different available modalities, and the pearls, pitfalls, and stop-gap measures useful in managing patients with gastric variceal bleed.
KEYWORDS
Gastric varices - portal hypertension - liver cirrhosis - BRTO - TIPS - splenorenal shunt - cyanoacrylate
REFERENCES
- 1 Sarin S K, Kumar A. Gastric varices: profile, classification, and management. Am J Gastroenterol. 1989; 84 (10) 1244-1249
- 2 Stray N, Jacobsen C D, Rosseland A. Injection sclerotherapy of bleeding oesophageal and gastric varices using a flexible endoscope. Acta Med Scand. 1982; 211 (1-2) 125-129
- 3 Sarin S K, Lahoti D, Saxena S P, Murthy N S, Makwana U K. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology. 1992; 16 (6) 1343-1349
- 4 Caldwell S H, Hespenheide E E, Greenwald B D, Northup P G, Patrie J T. Enbucrilate for gastric varices: extended experience in 92 patients. Aliment Pharmacol Ther. 2007; 26 (1) 49-59
- 5 Arakawa M, Masuzaki T, Okuda K. Pathology of fundic varices of the stomach and rupture. J Gastroenterol Hepatol. 2002; 17 (10) 1064-1069
- 6 Agarwal A K, Raj Kumar K, Agarwal S, Singh S. Significance of splenic vein thrombosis in chronic pancreatitis. Am J Surg. 2008; 196 (2) 149-154
- 7 Heider T R, Azeem S, Galanko J A, Behrns K E. The natural history of pancreatitis-induced splenic vein thrombosis. Ann Surg. 2004; 239 (6) 876-880 discussion 880-882
- 8 Ryan B M, Stockbrugger R W, Ryan J M. A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices. Gastroenterology. 2004; 126 (4) 1175-1189
- 9 Trudeau W, Prindiville T. Endoscopic injection sclerosis in bleeding gastric varices. Gastrointest Endosc. 1986; 32 (4) 264-268
- 10 Chey W D, Elta G H. Natural history of gastric varices. Gastroenterology. 1993; 105 (2) 599-602
- 11 Kim T, Shijo H, Kokawa H et al.. Risk factors for hemorrhage from gastric fundal varices. Hepatology. 1997; 25 (2) 307-312
- 12 Sarin S K. Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience. Gastrointest Endosc. 1997; 46 (1) 8-14
- 13 Jutabha R, Jensen D M, Kovacs T OG et al.. Initial results of combination banding and sclerotherapy compared to sclerotherapy alone for bleeding gastric varices. Gastrointest Endosc. 1998; 47 AB86
- 14 Scapa E. Treating gastrointestinal bleeding with endoscopic hemoclips. Surg Laparosc Endosc. 1997; 7 (2) 94-96
- 15 Kravetz D, Bosch J, Arderiu M, Pilar Pizcueta M, Rodés J. Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting. Hepatology. 1989; 9 (6) 808-814
- 16 Castañeda B, Morales J, Lionetti R et al.. Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats. Hepatology. 2001; 33 (4) 821-825
- 17 Villanueva C, Ortiz J, Miñana J et al.. Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology. 2001; 121 (1) 110-117
- 18 de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005; 43 (1) 167-176
- 19 Gabriel D A, Li X, Monroe III DMIII, Roberts H R. Recombinant human factor VIIa (rFVIIa) can activate factor FIX on activated platelets. J Thromb Haemost. 2004; 2 (10) 1816-1822
- 20 Porte R J, Molenaar I Q, Begliomini B EMSALT Study Group et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. Lancet. 2000; 355 (9212) 1303-1309
- 21 Westerkamp A C, Lisman T, Porte R J. How to minimize blood loss during liver surgery in patients with cirrhosis. HPB (Oxford). 2009; 11 (6) 453-458
- 22 Youssef W I, Salazar F D, Dasarathy S, Beddow T, Mullen K D. Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study. Am J Gastroenterol. 2003; 98 (6) 1391-1394
- 23 Porte R J, Lisman T, Tripodi A, Caldwell S H, Trotter J F. Coagulation in Liver Disease Study Group . The international normalized ratio (INR) in the MELD score: problems and solutions. Am J Transplant. 2010; 10 (6) 1349-1353
- 24 Trotter J F, Olson J, Lefkowitz J, Smith A D, Arjal R, Kenison J. Changes in international normalized ratio (INR) and model for endstage liver disease (MELD) based on selection of clinical laboratory. Am J Transplant. 2007; 7 (6) 1624-1628
- 25 Tripodi A, Primignani M, Chantarangkul V et al.. Thrombin generation in patients with cirrhosis: the role of platelets. Hepatology. 2006; 44 (2) 440-445
- 26 Hou M C, Lin H C, Kuo B I, Lee F Y, Schmidt C M, Lee S D. Clinical implications of the white nipple sign and its role in the diagnosis of esophageal variceal hemorrhage. Am J Gastroenterol. 1996; 91 (10) 2103-2109
- 27 Bosch J, Thabut D, Albillos A International Study Group on rFVIIa in UGI Hemorrhage et al. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial. Hepatology. 2008; 47 (5) 1604-1614
- 28 de Franchis R, Arcidiacono P G, Carpinelli L et al.. Randomized controlled trial of desmopressin plus terlipressin vs. terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: a multicenter, double-blind study. New Italian Endoscopic Club. Hepatology. 1993; 18 (5) 1102-1107
- 29 Sanyal A J, Freedman A M, Luketic V A et al.. Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial. Ann Intern Med. 1997; 126 (11) 849-857
- 30 Barange K, Péron J M, Imani K et al.. Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology. 1999; 30 (5) 1139-1143
- 31 Tripathi D, Therapondos G, Jackson E, Redhead D N, Hayes P C. The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. Gut. 2002; 51 (2) 270-274
- 32 Henderson J M, Boyer T D, Kutner M H DIVERT Study Group et al. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology. 2006; 130 (6) 1643-1651
- 33 Ferral H, Gamboa P, Postoak D W et al.. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score. Radiology. 2004; 231 (1) 231-236
- 34 Soehendra N, Grimm H, Nam V C, Berger B. N-butyl-2-cyanoacrylate: a supplement to endoscopic sclerotherapy. Endoscopy. 1987; 19 (6) 221-224
- 35 Rengstorff D S, Binmoeller K F. A pilot study of 2-octyl cyanoacrylate injection for treatment of gastric fundal varices in humans. Gastrointest Endosc. 2004; 59 (4) 553-558
- 36 Tan P C, Hou M C, Lin H C et al.. A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation. Hepatology. 2006; 43 (4) 690-697
- 37 Lo G H, Lai K H, Cheng J S, Chen M H, Chiang H T. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology. 2001; 33 (5) 1060-1064
- 38 Mahadeva S, Bellamy M C, Kessel D, Davies M H, Millson C E. Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. Am J Gastroenterol. 2003; 98 (12) 2688-2693
- 39 Greenwald B D, Caldwell S H, Hespenheide E E et al.. N-2-butyl-cyanoacrylate for bleeding gastric varices: a United States pilot study and cost analysis. Am J Gastroenterol. 2003; 98 (9) 1982-1988
- 40 Procaccini N J, Al-Osaimi A M, Northup P, Argo C, Caldwell S H. Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis. Gastrointest Endosc. 2009; 70 (5) 881-887
- 41 Lo G H, Liang H L, Chen W C et al.. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy. 2007; 39 (8) 679-685
- 42 Williams S G, Peters R A, Westaby D. Thrombin—an effective treatment for gastric variceal haemorrhage. Gut. 1994; 35 (9) 1287-1289
- 43 Przemioslo R T, McNair A, Williams R. Thrombin is effective in arresting bleeding from gastric variceal hemorrhage. Dig Dis Sci. 1999; 44 (4) 778-781
- 44 Yang W L, Tripathi D, Therapondos G, Todd A, Hayes P C. Endoscopic use of human thrombin in bleeding gastric varices. Am J Gastroenterol. 2002; 97 (6) 1381-1385
- 45 Ramesh J, Limdi J K, Sharma V, Makin A J. The use of thrombin injections in the management of bleeding gastric varices: a single-center experience. Gastrointest Endosc. 2008; 68 (5) 877-882
- 46 Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol. 1996; 11 (1) 51-58
- 47 Matsumoto A, Hamamoto N, Nomura T et al.. Balloon-occluded retrograde transvenous obliteration of high risk gastric fundal varices. Am J Gastroenterol. 1999; 94 (3) 643-649
- 48 Tanihata H, Minamiguchi H, Sato M et al.. Changes in portal systemic pressure gradient after balloon-occluded retrograde transvenous obliteration of gastric varices and aggravation of esophageal varices. Cardiovasc Intervent Radiol. 2009; 32 (6) 1209-1216
- 49 Cho S K, Shin S W, Do Y S et al.. Development of thrombus in the major systemic and portal veins after balloon-occluded retrograde transvenous obliteration for treating gastric variceal bleeding: its frequency and outcome evaluation with CT. J Vasc Interv Radiol. 2008; 19 (4) 529-538
- 50 Cho S K, Shin S W, Yoo E Y et al.. The short-term effects of balloon-occluded retrograde transvenous obliteration, for treating gastric variceal bleeding, on portal hypertensive changes: a CT evaluation. Korean J Radiol. 2007; 8 (6) 520-530
- 51 Sabri S S, Swee W, Turba U C et al.. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam. J Vasc Interv Radiol. 2011; 22 (3) 309-316 quiz 316
- 52 Sarin S K, Mishra S R. Endoscopic therapy for gastric varices. Clin Liver Dis. 2010; 14 (2) 263-279
- 53 Irani S, Kowdley K, Kozarek R. Gastric varices: an updated review of management. J Clin Gastroenterol. 2011; 45 (2) 133-148
- 54 Sakurabayashi S, Sezai S, Yamamoto Y, Hirano M, Oka H. Embolization of portal-systemic shunts in cirrhotic patients with chronic recurrent hepatic encephalopathy. Cardiovasc Intervent Radiol. 1997; 20 (2) 120-124
- 55 Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol. 2001; 12 (3) 327-336
Abdullah M. S. Al-OsaimiM.D. F.A.C.P. F.A.C.G. A.G.A.F.
Associate Professor of Medicine and Surgery, Medical Director of Liver Transplantation,
Division of Gastroenterology and Hepatology, Deparment of Medicine, University of
Virginia Health System
P.O. Box 800708, Charlottesville, VA 22908-0708
eMail: aa6h@virginia.edu